5-fluoro-1-(pyridin-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid | 1542160-39-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 英文名称: 5-fluoro-1-(pyridin-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
• 英文别名: 5-Fluoro-1-pyridin-2-ylpyrrolo[2,3-b]pyridine-3-carboxylic acid
• CAS: 1542160-39-3
• 化学式: C₁₃H₈FN₃O₂
• 分子量: 257.224
• InChiKey: MOUKSTCIHRDCOR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• [EN] 5-HT3 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 5-HT3
  申请人：ENVOY THERAPEUTICS INC

  公开号：WO2014014951A1

  公开（公告）日：2014-01-23

  The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  本发明提供了式(I)的5-HT3受体拮抗剂，用于治疗通过抑制5-HT3受体可治疗的疾病，如呕吐、疼痛、药物成瘾、神经退行性和精神障碍以及胃肠道疾病。还提供了含有这类化合物的药物组合物和制备这类化合物的方法。
• 5-HT3 RECEPTOR ANTAGONISTS
  申请人：ENVOY THERAPEUTICS, INC.

  公开号：US20140024644A1

  公开（公告）日：2014-01-23

  The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  本发明提供了5-HT3 受体拮抗剂的化学式 (I)：这些化合物对于治疗可通过抑制5-HT3 受体治疗的疾病，例如呕吐、疼痛、药物成瘾、神经退行性和精神障碍以及胃肠道疾病非常有用。还提供了包含这些化合物的制药组合物以及制备这些化合物的过程。
• 5-HT3 receptor antagonists
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US10125145B2

  公开（公告）日：2018-11-13

  The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  本发明提供了式 (I) 的 5-HT3 受体拮抗剂： 其可用于治疗可通过抑制 5-HT3 受体而治疗的疾病，如呃逆、疼痛、药物成瘾、神经退行性疾病、精神疾病和消化道疾病。此外，还提供了含有此类化合物的药物组合物以及制备此类化合物的工艺。
• US9012447B2
  申请人：——

  公开号：US9012447B2

  公开（公告）日：2015-04-21
• US9346829B2
  申请人：——

  公开号：US9346829B2

  公开（公告）日：2016-05-24